Shift Towards Personalized Healthcare Increases the Need for Pharmacogenomic Testing in Toxicology Labs: Fact.MR Reports
The toxicology laboratory industry in North America is projected to reach US$ 239.2 million in 2024 and is expected to witness a strong CAGR of 11.3% from 2024 to 2034. By 2034, the demand for toxicology laboratories is anticipated to reach a valuation of US$ 695.1 million.
Shift Towards Personalized Healthcare Increases the Need for Pharmacogenomic Testing in Toxicology Labs: Fact.MR Reports
The toxicology laboratory industry in North America is projected to reach US$ 239.2 million in 2024 and is expected to witness a strong CAGR of 11.3% from 2024 to 2034. By 2034, the demand for toxicology laboratories is anticipated to reach a valuation of US$ 695.1 million.
The toxicology laboratory sector in North America is growing due to growing consumer awareness of conventional testing equipment. Since limited substances are consumed in significant quantities in the United States and Canada, there is a growing demand for traditional toxicological testing equipment.
As traditional testing equipment is inexpensive and performs well, most toxicology laboratories that receive public funding rely on it. Since they are less expensive, hospitals and diagnostic testing facilities' toxicology laboratories adopt conventional technologies.
The toxicology laboratory demand in North America is constrained by complicated reimbursement schemes, strict regulatory requirements, and changing healthcare regulations. The North America market growth for toxicology laboratories is hindered by budgetary restrictions on healthcare spending and the high operating expenses of maintaining sophisticated diagnostic equipment.
The demand for toxicology laboratory services in North America is constrained, which inhibits the opportunity to expand due to the intense competition and healthcare provider collaborations.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9738
Key Takeaways of North America's Toxicology Laboratory Market Study:
The opiates/opioids segment in the drug class category will grab a share of 21% by 2034.
In the drug class category, the opiates/opioids segment is expected to evolve at a CAGR of 13.3% between 2024 and 2034.
In the product category, the reagents and kits segment to acquire a market share of 57.5% by 2034.
Thereagents and kits segment in the product category to accelerate at a CAGR of 11.4% from 2024 to 2034.
In the sample category, the urine segment to acquire a market share of 52.7% by 2034.
The hair segment in the sample category is to exhibit a CAGR of 13.7% from 2024 to 2034.
In the end-user category, the forensic laboratories segment to acquire a market share of 43.5% by 2034.
The diagnostic laboratories segment in the end user category to develop at a CAGR of 12.4% from 2024 to 2034.
The United Statessales of toxicology laboratory is anticipated to surge at a CAGR of 11% from 2024 to 2034.
Canada's demand for toxicology laboratoryto develop at a CAGR of 11.8% through 2034.
Mexicotoxicology laboratory sales are anticipated to surge at a CAGR of 9.1% between 2024 and 2034.
The United States is predicted to acquire a share of72.8% by 2034.
Canada is estimated to garner a share of 18.4% by 2034.
Mexico in toxicology laboratory industry is likely to grab a share of 6.5% by 2034.
“Due to the rising demand for toxicological testing services, the North America toxicology laboratory demand shows strong growth potential. Opportunities for market expansion of toxicology laboratory are created by changing regulatory environments and growing public awareness of environmental and occupational dangers.” opines an analyst
Country-wise Analysis
Demand for toxicology laboratories is growing in the United States due to rising demand for drug testing and increased awareness of workplace safety. The necessity for advanced toxicology services has increased due to the rise in opioid abuse cases, which has led to the United States market expansion of toxicology labs.
In Canada, the legalization of cannabis for recreational use has increased the demand for advanced toxicity testing techniques, which affects occupational safety as well as public health. Forensic toxicology is a rapidly expanding segment of the toxicology laboratory industry in Canada, with significant implications for legal investigations and law enforcement operations.
Leading Players Driving Innovation in the Toxicology Laboratory Industry Analysis in North America:
Key industry participants like Thermo Fisher Scientific, Inc; Danaher Corporation; Agilent Technologies; Alere, Inc.; Bio Rad Laboratories Inc.; Neogen Corporation; Bruker; WATERS; Redwood Toxicology Laboratory; Laboratory Corporation of America ©Holdings (MedTox Laboratories, Inc.) etc. are driving the toxicology laboratory industry analysis in North America.
Competitive Landscape
To strengthen their core capabilities, top instrument and reagent manufacturers serving the toxicology laboratory sector are concentrating on launching new products. The toxicology laboratory vendors in North America adjust their strategies strategically to produce outcomes quickly and effectively.
Noteworthy Developments:
In June 2023, Synaffix B.V., a biotechnology business devoted to commercializing its clinical-stage technological platform for the production of ADCs, was acquired by Lonza, a North American manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets. This aids in the company's North America expansion.
They announced the extension of clinical laboratory testing capabilities in Japan in May 2023 by BML and Labcorp Drug Development. This aids the business in bolstering its line of products in this area.
Thermo Fisher Scientific Inc. introduced a new liquid chromatography-mass spectrometry system for forensic toxicology in June 2022 to assist forensic toxicologists, clinical research toxicologists, employee drug testing facilities, and wellness organizations in staying abreast of new and illicit drug developments.
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=9738
More Valuable Insights
Fact.MR, in its new offering, presents an unbiased analysis of the global toxicology laboratory industry analysis in North America, presenting historical demand data and forecast statistics for the period (2024 to 2034).
The toxicology laboratory industry in North America is segmented by drug class, product, sample type, end user, and country. Drug classes include alcohol, amphetamines, barbiturates, benzodiazepines, opiates/opioids, tricyclic antidepressants, and Z drugs. Products are categorized into instruments and reagents/kits. Sample types include urine, blood, hair, and oral fluids. Key end users are hospitals and trauma centers, forensic laboratories, diagnostic laboratories, and rehabilitation centers. Geographically, the market is divided into the United States and Canada, reflecting regional demand for toxicology testing across medical, forensic, and clinical applications.
Check out More Related Studies Published by Fact.MR Research:
Laboratory developed test market size is anticipated to be worth US$ 8,698.6 million in 2024, and is projected to expand at a CAGR of 6.5%, resulting in a valuation of US$ 16,404.2 million by 2034.
Lab automation market size is anticipated to grow significantly, with a compound annual growth rate (CAGR) of 7% from 2022 to 2032, and is projected to reach from US$ 1.8 billion in 2021 to US$ 4 billion in 2032.
Primary hepatocytes market to reach a valuation of US$ 255.6 million by 2024 and projected to grow at a CAGR of 6.6% to reach US$ 486.6 million by 2034.
Preclinical CRO market size is valued at US$ 12.19 billion in 2024 and is forecasted to expand at a CAGR of 7.1% to reach a size of US$ 24.15 billion by the end of 2034.
Organs-on-chips market size is valued at US$ 103 million in 2023 and is predicted to surge and attain an impressive valuation of US$ 1.45 billion by 2033-end.
